D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

Pink hydrogen offers significant market opportunities by leveraging nuclear energy for stable, efficient hydrogen production.